The gonadotropin connection in Alzheimer's disease
- PMID: 16034187
- DOI: 10.1385/ENDO:26:3:317
The gonadotropin connection in Alzheimer's disease
Abstract
Although not traditionally thought of as regulators of neuronal function, the hypothalamic-pituitary-gonadal (HPG) hormones luteinizing hormone (LH), gonadotropin-releasing hormone (GnRH), and activins possess neuronal receptors. These receptors are found throughout the limbic system on a number of different cell types, and, like reproductive tissues, the expression of these receptors is regulated by hormonal feedback loops. These hormones and their receptors regulate structure and a diverse range of functions in the brain. Therefore, it is not surprising that the dysregulation of the HPG axis with menopause and andropause (leading to elevated LH, GnRH, and activin signaling but decreased sex steroid signaling) might promote alterations in both the structure and function of neuronal cells. To date, most evidence has accumulated for a role of LH in promoting neurodegenerative changes. LH is known to cross the blood-brain barrier, receptors for LH are most concentrated in the hippocampus, that region of the brain most vulnerable to Alzheimer's disease (AD) and LH is significantly elevated in both the serum and the pyramidal neurons of AD subjects. LH promotes the amyloidogenic processing of the amyloid-beta precursor protein in vitro, and the antigonadotropin leuprolide acetate decreases amyloid generation in mice. Moreover, leuprolide acetate improves the cognitive performance and decreases amyloid-beta deposition in aged transgenic mice carrying the Swedish AbetaPP mutation. Therefore, the elevation of LH with the dysregulation of the HPG axis at menopause and andropause is a physiologically relevant signal that could promote neurodegeneration. Epidemiological support for a role of LH/GnRH in AD is evidenced by a reduction in neurodegenerative disease among prostate cancer patients a group known to GnRH agonists. Clinical trials are underway for the treatment of AD using GnRH analogs and should provide further insights into the gonadotropin connection in AD.
Similar articles
-
Dysregulation of the hypothalamic-pituitary-gonadal axis with menopause and andropause promotes neurodegenerative senescence.J Neuropathol Exp Neurol. 2005 Feb;64(2):93-103. doi: 10.1093/jnen/64.2.93. J Neuropathol Exp Neurol. 2005. PMID: 15751223 Review.
-
The role of hypothalamic-pituitary-gonadal hormones in the normal structure and functioning of the brain.Cell Mol Life Sci. 2005 Feb;62(3):257-70. doi: 10.1007/s00018-004-4381-3. Cell Mol Life Sci. 2005. PMID: 15723162 Review.
-
Luteinizing hormone, a reproductive regulator that modulates the processing of amyloid-beta precursor protein and amyloid-beta deposition.J Biol Chem. 2004 May 7;279(19):20539-45. doi: 10.1074/jbc.M311993200. Epub 2004 Feb 9. J Biol Chem. 2004. PMID: 14871891
-
Luteinizing hormone modulates cognition and amyloid-beta deposition in Alzheimer APP transgenic mice.Biochim Biophys Acta. 2006 Apr;1762(4):447-52. doi: 10.1016/j.bbadis.2006.01.008. Epub 2006 Feb 13. Biochim Biophys Acta. 2006. PMID: 16503402
-
Elevated mRNA-levels of gonadotropin-releasing hormone and its receptor in plaque-bearing Alzheimer's disease transgenic mice.PLoS One. 2014 Aug 4;9(8):e103607. doi: 10.1371/journal.pone.0103607. eCollection 2014. PLoS One. 2014. PMID: 25089901 Free PMC article.
Cited by
-
Sex steroid levels and AD-like pathology in 3xTgAD mice.J Neuroendocrinol. 2013 Feb;25(2):131-144. doi: 10.1111/j.1365-2826.2012.02374.x. J Neuroendocrinol. 2013. PMID: 22889357 Free PMC article.
-
Hormonal and morphological study of the pituitaries in reeler mice.Int J Exp Pathol. 2007 Jun;88(3):165-73. doi: 10.1111/j.1365-2613.2007.00528.x. Int J Exp Pathol. 2007. PMID: 17504446 Free PMC article.
-
In Silico Investigation of the Pharmacological Mechanisms of Beneficial Effects of Ginkgo biloba L. on Alzheimer's Disease.Nutrients. 2018 May 10;10(5):589. doi: 10.3390/nu10050589. Nutrients. 2018. PMID: 29747475 Free PMC article.
-
Plasma growth hormones, P300 event-related potential and test of variables of attention (TOVA) are important neuroendocrinological predictors of early cognitive decline in a clinical setting: evidence supported by structural equation modeling (SEM) parameter estimates.Age (Dordr). 2007 Sep;29(2-3):55-67. doi: 10.1007/s11357-007-9030-3. Epub 2007 May 12. Age (Dordr). 2007. PMID: 19424831 Free PMC article.
-
Gene-dose-dependent reduction of Fshr expression improves spatial memory deficits in Alzheimer's mice.Mol Psychiatry. 2024 Nov 15. doi: 10.1038/s41380-024-02824-x. Online ahead of print. Mol Psychiatry. 2024. PMID: 39548323
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical